N/A
Manufactured by Viatris Specialty LLC
36,996 FDA adverse event reports analyzed
Last updated: 2026-04-14
PHENYTOIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Viatris Specialty LLC. The most commonly reported adverse reactions for PHENYTOIN include DRUG INEFFECTIVE, DRUG INTERACTION, SEIZURE, TOXICITY TO VARIOUS AGENTS, CONVULSION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PHENYTOIN.
Out of 20,447 classified reports for PHENYTOIN:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 36,996 FDA FAERS reports that mention PHENYTOIN. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, DRUG INTERACTION, SEIZURE, TOXICITY TO VARIOUS AGENTS, CONVULSION, OFF LABEL USE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Viatris Specialty LLC in connection with PHENYTOIN. Always verify the specific product and NDC with your pharmacist.